Decoding inflammation, its causes, genomic responses, and emerging countermeasures
Open Access
- 4 August 2019
- journal article
- review article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 90 (6), e12812
- https://doi.org/10.1111/sji.12812
Abstract
Inflammation is the mechanism of diseases caused by microbial, autoimmune, allergic, metabolic and physical insults that produce distinct types of inflammatory responses. This aetiologic view of inflammation informs its classification based on a cause‐dependent mechanism as well as a cause‐directed therapy and prevention. The genomic era ushered in a new understanding of inflammation by highlighting the cell's nucleus as the centre of the inflammatory response. Exogenous or endogenous inflammatory insults evoke genomic responses in immune and non‐immune cells. These genomic responses depend on transcription factors, which switch on and off a myriad of inflammatory genes through their regulatory networks. We discuss the transcriptional paradigm of inflammation based on denying transcription factors’ access to the nucleus. We present two approaches that control proinflammatory signalling to the nucleus. The first approach constitutes a novel intracellular protein therapy with bioengineered physiologic suppressors of cytokine signalling. The second approach entails control of proinflammatory transcriptional cascades by targeting nuclear transport with a cell‐penetrating peptide that inhibits the expression of 23 out of the 26 mediators of inflammation along with the nine genes required for metabolic responses. We compare these emerging anti‐inflammatory countermeasures to current therapies. The transcriptional paradigm of inflammation offers nucleocentric strategies for microbial, autoimmune, metabolic, physical and other types of inflammation afflicting millions of people worldwide.Keywords
Funding Information
- U.S. Department of Veterans Affairs (BX002750)
This publication has 282 references indexed in Scilit:
- Bcl10 Links Saturated Fat Overnutrition with Hepatocellular NF-κB Activation and Insulin ResistanceCell Reports, 2012
- The many faces of Th17 cellsCurrent Opinion in Immunology, 2011
- Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cellsCurrent Opinion in Immunology, 2011
- Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in MiceImmunity, 2011
- Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1aCell Metabolism, 2011
- The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitisJournal of Neuroimmunology, 2011
- The STING pathway and regulation of innate immune signaling in response to DNA pathogensCellular and Molecular Life Sciences, 2010
- Selective Transcription in Response to an Inflammatory StimulusCell, 2010
- Cell penetrating peptide inhibitors of Nuclear Factor-kappa BCellular and Molecular Life Sciences, 2008
- Selective versus Total Insulin Resistance: A Pathogenic ParadoxCell Metabolism, 2008